Literature DB >> 10072074

T cell receptor and coreceptor CD8 alphaalpha bind peptide-MHC independently and with distinct kinetics.

J R Wyer1, B E Willcox, G F Gao, U C Gerth, S J Davis, J I Bell, P A van der Merwe, B K Jakobsen.   

Abstract

The T cell surface glycoprotein CD8 enhances T cell antigen recognition by binding to MHC class I molecules. We show that human CD8 alphaalpha binds to the MHC class I molecule HLA-A2 with an extremely low affinity (Kd approximately 0.2 mM at 37 degrees C) and with kinetics that are between 2 and 3 orders of magnitude faster than reported for T cell receptor/peptide-MHC interactions. Furthermore, CD8 alphaalpha had no detectable effect on a T cell receptor (TCR) binding to the same peptide-MHC class I complex. These binding properties provide an explanation as to why the CD8/MHC class I interaction is unable to initiate cell-cell adhesion and how it can enhance TCR recognition without interfering with its specificity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10072074     DOI: 10.1016/s1074-7613(00)80022-9

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  82 in total

1.  Production of soluble alphabeta T-cell receptor heterodimers suitable for biophysical analysis of ligand binding.

Authors:  B E Willcox; G F Gao; J R Wyer; C A O'Callaghan; J M Boulter; E Y Jones; P A van der Merwe; J I Bell; B K Jakobsen
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

2.  Differences in antigen recognition and cytolytic activity of CD8(+) and CD8(-) T cells that express the same antigen-specific receptor.

Authors:  B K Cho; K C Lian; P Lee; A Brunmark; C McKinley; J Chen; D M Kranz; H N Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

3.  Breaking the affinity ceiling for antibodies and T cell receptors.

Authors:  J Foote; H N Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

4.  Structural and energetic evidence for highly peptide-specific tumor antigen targeting via allo-MHC restriction.

Authors:  Amy A Simpson; Fiyaz Mohammed; Mahboob Salim; Amy Tranter; Alan B Rickinson; Hans J Stauss; Paul A H Moss; Neil M Steven; Benjamin E Willcox
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

5.  Interplay between TCR affinity and necessity of coreceptor ligation: high-affinity peptide-MHC/TCR interaction overcomes lack of CD8 engagement.

Authors:  Samantha E Kerry; Jennifer Buslepp; Lorraine A Cramer; Robert Maile; Lucinda L Hensley; Alma I Nielsen; Paula Kavathas; Barbara J Vilen; Edward J Collins; Jeffrey A Frelinger
Journal:  J Immunol       Date:  2003-11-01       Impact factor: 5.422

6.  Persistent viral infection in humans can drive high frequency low-affinity T-cell expansions.

Authors:  Naeem Khan; Mark Cobbold; Joanne Cummerson; Paul A H Moss
Journal:  Immunology       Date:  2010-08-16       Impact factor: 7.397

7.  T cell receptor interactions with class I heavy-chain influence T cell selection.

Authors:  S T Kuhns; M D Tallquist; A J Johnson; Y Mendez-Fernandez; L R Pease
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

8.  CD8 kinetically promotes ligand binding to the T-cell antigen receptor.

Authors:  Dmitry M Gakamsky; Immanuel F Luescher; Aladdin Pramanik; Ronen B Kopito; François Lemonnier; Horst Vogel; Rudolf Rigler; Israel Pecht
Journal:  Biophys J       Date:  2005-06-24       Impact factor: 4.033

9.  Nonstimulatory peptides contribute to antigen-induced CD8-T cell receptor interaction at the immunological synapse.

Authors:  Pia P Yachi; Jeanette Ampudia; Nicholas R J Gascoigne; Tomasz Zal
Journal:  Nat Immunol       Date:  2005-06-26       Impact factor: 25.606

10.  Quantum dot/peptide-MHC biosensors reveal strong CD8-dependent cooperation between self and viral antigens that augment the T cell response.

Authors:  Nadia Anikeeva; Tatiana Lebedeva; Aaron R Clapp; Ellen R Goldman; Michael L Dustin; Hedi Mattoussi; Yuri Sykulev
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-31       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.